Báo cáo khoa học: "Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care giúp cho các bạn có thêm kiến thức về ngành y học đề tài: Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective. | Available online http content 10 4 R120 Research Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding - a European perspective Jean-Louis Vincent1 Rolf Rossaint2 Bruno Riou3 Yves Ozier4 David Zideman5 and Donat R Spahn6 1 Department of Intensive Care Erasme Hospital Free University of Brussels Route de Lennik 808 1070 Brussels Belgium 2Department of Anaesthesiology of the University Hospital RWTH Pauwelsstrasse 30 52074 Aachen Germany 3Department of Emergency Medicine and Surgery and Department of Anesthesiology and Critical Care Hôpital Pitié-Salpêtrière Assistance Publique-Hôpitaux de Paris Université Pierre et Marie Curie 47-83 Boulevard de l Hôpital 75651 Paris France 4Service d Anesthésie-Réanimation Chirurgicale Hôpital Cochin Assistance publique-Hôpitaux de Paris Faculté de Medecine Paris-V Université Rene-Descartes 27 Rue du faubourg Saint-Jacques 75679 Paris France 5European Resuscitation Council ERC Secretariat Universiteitsplein 1 2610 Antwerp Belgium 6Department of Anaesthesiology University Hospital Lausanne Rue du Bugnon 46 1 011 Lausanne Switzerland Corresponding author Jean-Louis Vincent jlvincent@ Received 10 Jun 2006 Accepted 18 Aug 2006 Published 18 Aug 2006 Critical Care 2006 10 R120 doi cc5026 This article is online at http content 10 4 R1 20 2006 Vincent et al. licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Open Access Abstract Introduction Our aim was to develop consensus guidelines for use of recombinant activated factor VII rFVIla in massive hemorrhage. Methods A guidelines committee derived the recommendations using clinical trial and case series data identified through searches of available .

Không thể tạo bản xem trước, hãy bấm tải xuống
TỪ KHÓA LIÊN QUAN
TÀI LIỆU MỚI ĐĂNG
100    120    2    28-06-2024
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.